Adebayo GI et al., 1988-08: Volunteer study testing whether benzimidazoles inhibit hepatic cytochrome P450: mebendazole 100 mg twice daily for three days did not change theophylline disposition, while cimetidine did – evidence that mebendazole's metabolic-inhibition effect is weak at standard doses.
Mebendazole at a dose of 100 mg b.d. for 3 days did not significantly alter the theophylline half-life, volume of distribution or clearance in a group of six.
Adebayo GI et al., 1988-08: Volunteer study testing whether benzimidazoles inhibit hepatic cytochrome P450: mebendazole 100 mg twice daily for three days did not change theophylline disposition, while cimetidine did – evidence that mebendazole's metabolic-inhibition effect is weak at standard doses.
